Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
12.83
+0.93 (7.82%)
At close: Oct 20, 2026, 4:00 PM EDT
12.76
-0.07 (-0.55%)
After-hours: Oct 20, 2026, 7:46 PM EDT
Trevi Therapeutics Market Cap
Trevi Therapeutics has a market cap or net worth of $1.83 billion as of October 20, 2026. It is the 7,051st most valuable company in the world and the 1,828th biggest in the United States. Its market cap has increased by 44.89% in one year.
Market Cap
1.83B
Enterprise Value
1.51B
1-Year Change
44.89%
Global Rank
Country Rank
#1,828 United States
Category
ChartMarket Cap Chart
Since May 7, 2019, Trevi Therapeutics's market cap has increased from $84.99M to $1.83B, an increase of 2,050.82%. That is a compound annual growth rate of 50.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2026 | 1.83B | 13.86% |
| Dec 31, 2025 | 1.61B | 336.04% |
| Dec 31, 2024 | 368.19M | 330.28% |
| Dec 29, 2023 | 85.57M | -26.01% |
| Dec 30, 2022 | 115.65M | 472.04% |
| Dec 31, 2021 | 20.22M | -54.55% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 7, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Novavax | 1.78B |
| Palvella Therapeutics | 1.77B |
| Zenas BioPharma | 1.74B |
| Vir Biotechnology | 1.73B |
| Xencor | 1.72B |
| Biohaven | 1.71B |
| Septerna | 1.70B |
| UroGen Pharma | 1.67B |